Stock Earnings

Question 1

Cue Biopharma Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Cue Biopharma Inc'in toplam varlıkları $32 olup, net loss $-40'dir.

Question 2

CUE'ün temel finansal oranları nelerdir?

Accepted Answer

Cue Biopharma Inc'in cari oranı 2.28, net kâr marjı -444.44, hisse başına satış $0.15'dir.

Question 3

Cue Biopharma Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Cue Biopharma Inc largest revenue segment is Injectable Biologics, at a revenue of 9,287,000 in the most earnings release.For geography, United States is the primary market for Cue Biopharma Inc, at a revenue of 9,287,000.

Question 4

Cue Biopharma Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Cue Biopharma Inc'in net loss $-40'dir.

Question 5

Cue Biopharma Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Cue Biopharma Inc'in yükümlülüğü 14'dir.

Question 6

Cue Biopharma Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Cue Biopharma Inc'in toplam tedavüldeki hisse sayısı 61.81'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	8	9	5	1	14	3
Revenue Growth (YoY)	0%	80%	400%	-93%	367%	0%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	14	14	16	16	17	14
Research & Development	33	35	40	37	40	32
Operating Expenses	47	50	57	54	58	48
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-38	-40	-50	-53	-43	-44
Income Tax Expense	--	--	--	0	0	0
Net Income	-38	-40	-50	-53	-44	-44
Net Income Growth	-17%	-20%	-6%	20%	0%	22%
Shares Outstanding (Diluted)	95.45	56.32	45.75	35.65	31.29	28.69
Shares Change (YoY)	90%	23%	28%	14%	9%	30%
EPS (Diluted)	-0.4	-0.72	-1.1	-1.49	-1.41	-1.56
EPS Growth	-56.99%	-35%	-26%	6%	-10%	-6%
Free Cash Flow	-28	-36	-39	-41	-39	-33
Free Cash Flow Per Share	-0.29	-0.63	-0.85	-1.15	-1.24	-1.15
Gross Margin	--	--	--	--	--	--
Operating Margin	-487.5%	-455.55%	-1,019.99%	-5,300%	-307.14%	-1,500%
Profit Margin	-475%	-444.44%	-1,000%	-5,300%	-314.28%	-1,466.66%
Free Cash Flow Margin	-350%	-400%	-780%	-4,100%	-278.57%	-1,100%
EBITDA	-39	-41	-51	-53	-42	-44
EBITDA Margin	-487.5%	-455.55%	-1,019.99%	-5,300%	-300%	-1,466.66%
D&A For EBITDA	0	0	0	0	1	1
EBIT	-39	-41	-51	-53	-43	-45
EBIT Margin	-487.5%	-455.55%	-1,019.99%	-5,300%	-307.14%	-1,500%
Effective Tax Rate	--	--	--	0%	0%	0%

Cue Biopharma Inc (CUE) Price

CUE Stock Price Chart

CUE Income

Follow-Up Questions